Copy to clipboard 
Colson Medical announced Hjalmar Pompe van Meerdervoort as the new President of Acumed, effective June 1. Pompe van Meerdervoort succeeds Sharon Wolfington, who will transition into a new advisory role for Colson Medical. After nearly five years at Acumed, Wolfington chose to pursue other professional and personal opportunities.
Pompe van Meerdervoort brings extensive global healthcare experience with his more than 25-year career in orthopedics and medical devices. Most recently, he was Senior Vice President and General Manager, Reconstruction at Smith+Nephew where he led the commercial functions for Smith+Nephew’s reconstructive joint portfolio.
Hjalmar Pompe van Meerdervoort. Photo courtesy of CISION PRWeb.
Prior to Smith+Nephew, Pompe van Meerdervoort served as co-founder and CEO of VisionScope Technologies, an office-based arthroscopic imaging company. He was also Vice President and General Manager, Knees, at Zimmer Holdings, where he managed the company’s $2 billion flagship segment. He spent more than 10 years of his early career at Stryker, growing his responsibility and reach to include international assignments.
“Over the past few months, we have conducted an extensive search to select the next leader of Acumed,” said Chris J. Smith, President, Colson Medical. “With his exceptional track record of leading teams and businesses to achieve superior results, we believe Hjalmar is the ideal President to lead Acumed in its next chapter of growth and success.”
Wolfington will transition into a new advisory role at Colson Medical focused on key areas including thought leader management, business development, and clinical research strategy.
